All In Biotech

Free tool

FAERS Monitor: Gleevec

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021588 or its brand name (Gleevec, Imatinib Mesylate). Reports on generic versions are filed under their own applications.

Reports

27,809

Serious

20,991

75% of reports

Hospitalization

6,162

Death reported

6,801

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death4,640
  • nausea2,144
  • diarrhoea1,773
  • fatigue1,533
  • drug ineffective1,396
  • vomiting1,291
  • malaise1,082
  • rash1,003
  • dyspnoea995
  • muscle spasms862
  • neoplasm malignant847
  • asthenia806
  • pyrexia774
  • anaemia720
  • malignant neoplasm progression686

Reports by year received

View as table
YearReports
2004638
2005712
2006687
2007717
2008727
20091,136
20101,568
20113,282
20123,332
20131,010
2014619
20151,009
20161,668
20171,518
20181,567
20191,761
20201,390
20211,147
20221,012
20231,022
2024623
2025363
2026296

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,026,350 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neoplasm malignantSignal8479.79.16,544
malignant neoplasm progressionSignal6865.14.72,249
deathSignal4,6404.14.011,231
muscle spasmsSignal8623.63.31,594
anaemiaSignal7202.92.7875
diarrhoeaSignal1,7732.12.01,022
vomitingSignal1,2912.12.0737
nauseaSignal2,1442.12.01,197
malaise1,0821.91.8444
rash1,0031.71.6322
pyrexia7741.71.6222
asthenia8061.61.5195
fatigue1,5331.51.4256
dyspnoea9951.31.383
drug ineffective1,3960.80.873

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.